Urothelial carcinoma of the bladder and the upper tract: Disparate twins

Journal of Urology

Volumn 189, Issue 4, 2013, Pages 1214-1221

  Green, David A ^a   Rink, Michael ^a   Xylinas, Evanguelos ^a,d   Matin, Surena F ^f   Stenzl, Arnulf ^c   Roupret, Morgan ^b,d,e   Karakiewicz, Pierre I ^g   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF TEXAS   (United States)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

adjuvant; carcinoma; chemotherapy; neoplasm staging; transitional cell; urinary bladder neoplasms; urinary tract

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ANATOMY; BLADDER CANCER; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; ENDOSCOPY; EVIDENCE BASED MEDICINE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; MEDLINE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PUBLICATION; REVIEW; SEX; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TWINS;

CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84875918605     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.05.079     Document Type: Review

References (50)

1. R. Siegel, D. Naishadham, A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10
2. M.F. Botteman, C.L. Pashos, A. Redaelli The health economics of bladder cancer: a comprehensive review of the published literature Pharmacoeconomics 21 2003 1315
3. M. Rouprêt, R. Zigeuner, J. Palou European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584
4. B.P. Rai, M. Shelley, B. Coles Surgical management for upper urinary tract transitional cell carcinoma Cochrane Database Syst Rev 4 2011 CD007349>
5. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Bladder Cancer V.2.2012.
6. M.C. Hall, S.S. Chang, G. Dalbagni Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314
7. M. Soloway, A. Carmack, S. Khoury First International Consultation on Bladder Tumors 21 2006 Editions Paris
8. H. Fajkovic, J.A. Halpern, E.K. Cha Impact of gender on bladder cancer incidence, staging, and prognosis World J Urol 29 2011 457
9. G. Lughezzani, M. Sun, P. Perrotte Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database Urology 75 2010 321
10. M.I. Fernández, S.F. Shariat, V. Margulis Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study Urology 73 2009 142
11. S.F. Shariat, R.L. Favaretto, A. Gupta Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma World J Urol 29 2011 481
12. E. Scosyrev, K. Noyes, C. Feng Sex and racial differences in bladder cancer presentation and mortality in the US Cancer 115 2009 68
13. M.E. Nielsen, S.F. Shariat, P.I. Karakiewicz Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy Eur Urol 51 2007 699
14. D. Tilki, R.S. Svatek, G. Novara Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients J Urol 184 2010 888
15. D. Tilki, O. Reich, R.S. Svatek Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients J Urol 183 2010 1757
16. D. Tilki, R.S. Svatek, P.I. Karakiewicz Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients J Urol 183 2010 87
17. S.S. Shen, C.L. Smith, J.T. Hsieh Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue Cancer 106 2006 2610
18. H. Miyamoto, J.L. Yao, A. Chaux Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder BJU Int 109 2012 1716
19. C. Bolenz, Y. Lotan, R. Ashfaq Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder Eur Urol 56 2009 1093
20. V. Margulis, R.F. Youssef, P.I. Karakiewicz Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract J Urol 184 2010 453
21. F.A. Yafi, G. Novara, S.F. Shariat Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy BJU Int 110 2012 E7
22. J.D. Raman, C.K. Ng, D.S. Scherr Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy Eur Urol 57 2010 1072
23. R.L. Favaretto, S.F. Shariat, D.C. Chade The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center Eur Urol 58 2010 574
24. E.K. Cha, S.F. Shariat, M. Kormaksson Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma Eur Urol 61 2012 818
25. J.W. Catto, D.R. Yates, I. Rehman Behavior of urothelial carcinoma with respect to anatomical location J Urol 177 2007 1715
26. S. Moussa, F.A. Yafi, A. El-Hakim Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison Urol Int 84 2010 50
27. M. Rink, B. Ehdaie, E.K. Cha Stage-specific impact of tumor location on oncological outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery Eur Urol 62 2012 677
28. M. Babjuk, W. Oosterlinck, R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997
29. S.B. Edge, D.R. Byrd, C.C. Compton AJCC Cancer Staging Manual 7th ed. 2010 Springer New York
30. M. Grasso, A.I. Fishman, J. Cohen Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients BJU Int 110 2012 1618
31. A.K. Smith, A.J. Stephenson, B.R. Lane Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management Urology 78 2011 82
32. A. El-Assmy, M.E. Abou-El-Ghar, A. Mosbah Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging Eur Radiol 19 2009 1575
33. M. Takeuchi, S. Sasaki, M. Ito Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade Radiology 251 2009 112
34. Y. Ito, E. Kikuchi, N. Tanaka Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma J Urol 185 2011 1621
35. R.L. Favaretto, S.F. Shariat, C. Savage Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma BJU Int 109 2012 77
36. M.J. Scolieri, M.L. Paik, S.L. Brown Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma Urology 56 2000 930
37. G.A. Fritz, H. Schoellnast, H.A. Deutschmann Multiphasic multidetector-row CT (MDCT) in detection and staging of transitional cell carcinomas of the upper urinary tract Eur Radiol 16 2006 1244
38. P.I. Karakiewicz, S.F. Shariat, G.S. Palapattu Precystectomy nomogram for prediction of advanced bladder cancer stage Eur Urol 50 2006 1254
39. S.F. Matin, A.M. Kamat, H.B. Grossman High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation J Ultrasound Med 29 2010 1277
40. G. Giannarini, T.M. Kessler, F.D. Birkhäuser Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol 60 2011 955
41. M. Babjuk What are the limitations of endoscopic management of urothelial carcinoma of the upper urinary tract? Eur Urol 60 2011 961
42. A. Huang, R.K. Low, R. deVere White Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma J Urol 153 1995 1041
43. G.N. Thalmann, R. Markwalder, B. Walter Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery J Urol 168 2002 1381
44. N. Nonomura, Y. Ono, M. Nozawa Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract Eur Urol 38 2000 701
45. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666
46. S.F. Shariat, B. Ehdaie, M. Rink Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment Eur Urol 61 2012 237
47. M. Roscigno, S.F. Shariat, V. Margulis Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy J Urol 181 2009 2482
48. G. Lughezzani, C. Jeldres, H. Isbarn A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma Urology 75 2010 118
49. T.M. Koppie, A.J. Vickers, K. Vora Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 107 2006 2368
50. W. Kassouf, R.S. Svatek, S.F. Shariat Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder Urol Oncol April 7, 2011 Epub ahead of print